首页 > 最新文献

Hospital practice (1995)最新文献

英文 中文
Renally inappropriate medications in elderly outpatients and inpatients with an impaired renal function. 老年门诊和住院肾功能受损患者用药不当。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.1080/21548331.2023.2173412
Shotaro Kobayashi, Norio Sugama, Hiroyuki Nagano, Masahiro Takahashi, Akifumi Kushiyama

Background and aims: The purpose of this study was to investigate differences in the frequency of renally inappropriate medications (RIMs) in outpatient and inpatient among three institutions.

Methods: We collected prescription and renal function data for patients over 65 years of age from the drug department system. We selected 50 kinds of the most frequently used medicines which require dose adjustment according to a patient's renal function.

Results: Outpatient RIM was seen in 611 cases (6.17%), and inpatient prescription RIM was seen in 317 cases (5.29%), showing a significant difference between the groups (odds ratio [OR] 1.18, 95% confidence interval [CI] 1.02-1.35). However, in a multivariate analysis, when the renal function was included, that difference between outpatients and inpatients became insignificant (OR 1.16, 95% CI 0.98-1.37). The distribution of prescription with or without RIM in outpatient and inpatient settings depended on the CKD stage. Outpatients with a better CKD stage (stage 1-3) had a higher rate of RIM than inpatients, while patients with a worse CKD stage (stage 4 or 5) had a higher rate of RIM than outpatients.

Conclusion: The rate of RIM in outpatients tends to be high, and attention should be paid to RIM in inpatients with a severe CKD stage.

背景与目的:本研究的目的是调查三家医院门诊和住院患者肾不适当药物使用频率的差异。方法:从药科系统收集65岁以上患者的处方和肾功能资料。我们选择了50种最常用的药物,需要根据患者的肾功能调整剂量。结果:门诊RIM 611例(6.17%),住院处方RIM 317例(5.29%),两组比较差异有统计学意义(优势比[OR] 1.18, 95%可信区间[CI] 1.02 ~ 1.35)。然而,在多变量分析中,当包括肾功能时,门诊患者和住院患者之间的差异变得不显著(OR 1.16, 95% CI 0.98-1.37)。门诊和住院的处方中有或没有RIM的分布取决于CKD的分期。CKD分期较好(1-3期)的门诊患者RIM率高于住院患者,而CKD分期较差(4期或5期)的患者RIM率高于门诊患者。结论:门诊患者RIM发生率偏高,重症CKD住院患者应重视RIM的治疗。
{"title":"Renally inappropriate medications in elderly outpatients and inpatients with an impaired renal function.","authors":"Shotaro Kobayashi,&nbsp;Norio Sugama,&nbsp;Hiroyuki Nagano,&nbsp;Masahiro Takahashi,&nbsp;Akifumi Kushiyama","doi":"10.1080/21548331.2023.2173412","DOIUrl":"https://doi.org/10.1080/21548331.2023.2173412","url":null,"abstract":"<p><strong>Background and aims: </strong>The purpose of this study was to investigate differences in the frequency of renally inappropriate medications (RIMs) in outpatient and inpatient among three institutions.</p><p><strong>Methods: </strong>We collected prescription and renal function data for patients over 65 years of age from the drug department system. We selected 50 kinds of the most frequently used medicines which require dose adjustment according to a patient's renal function.</p><p><strong>Results: </strong>Outpatient RIM was seen in 611 cases (6.17%), and inpatient prescription RIM was seen in 317 cases (5.29%), showing a significant difference between the groups (odds ratio [OR] 1.18, 95% confidence interval [CI] 1.02-1.35). However, in a multivariate analysis, when the renal function was included, that difference between outpatients and inpatients became insignificant (OR 1.16, 95% CI 0.98-1.37). The distribution of prescription with or without RIM in outpatient and inpatient settings depended on the CKD stage. Outpatients with a better CKD stage (stage 1-3) had a higher rate of RIM than inpatients, while patients with a worse CKD stage (stage 4 or 5) had a higher rate of RIM than outpatients.</p><p><strong>Conclusion: </strong>The rate of RIM in outpatients tends to be high, and attention should be paid to RIM in inpatients with a severe CKD stage.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9202932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of dornase alfa in pediatric patients without cystic fibrosis. 无囊性纤维化的儿童患者中dornase alfa的应用。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.1080/21548331.2023.2176041
Krishna C Daiya, Caroline M Sierra

Objectives: Literature regarding clinical benefits of dornase alfa (DNase) in pediatric patients without cystic fibrosis is lacking. In December 2020, the study institution implemented restrictions to limit DNase use in this patient population. The primary objective was adherence to DNase ordering restrictions. Secondary objectives included length of stay, respiratory function, and use of inhaled mucolytic agents.

Methods: This single-center retrospective chart review included patients less than 18 years of age who received DNase one year prior to through one year after order restriction implementation. Data collected included patient demographics and respiratory clinical parameters. Dosing regimens for DNase, n-acetylcysteine, and hypertonic saline were collected, as well as changes in length of stay (LOS) and adherence to ordering restrictions.

Results: Of 101 total DNase orders, 45 were placed after implementation of ordering restrictions and 16 (36%) met all ordering criteria. Hospital and intensive care unit (ICU) LOS after implementation of restrictions were not significantly different (p = 0.767 and p = 0.219, respectively). There was no significant change in patients' mean oxygenation index (p = 0.252) or FiO2% (p = 0.113) 24 hours after DA administration.

Conclusion: Respiratory function did not significantly change after DNase administration. Implementing restrictions on DNase did not impact intensive care unit or hospital LOS. Adherence to DNase ordering restrictions could be improved.

目的:缺乏关于无囊性纤维化的儿童患者使用脱氧核糖核酸酶(DNase)的临床益处的文献。2020年12月,该研究机构实施了限制措施,以限制该患者群体中DNase的使用。主要目标是遵守DNase排序限制。次要目标包括住院时间、呼吸功能和吸入黏液溶解剂的使用。方法:本单中心回顾性图表回顾包括18岁以下的患者,他们在实施限药前一年到限药后一年接受DNase治疗。收集的数据包括患者人口统计学和呼吸临床参数。收集DNase、n-乙酰半胱氨酸和高渗盐水的给药方案,以及住院时间(LOS)的变化和对医嘱限制的依从性。结果:101份DNase订单中,45份是在实施订购限制后下单的,16份(36%)符合所有订购标准。实施限制措施后,医院和重症监护病房(ICU)的LOS差异无统计学意义(p = 0.767和p = 0.219)。给药24小时后患者平均氧合指数(p = 0.252)和FiO2% (p = 0.113)无显著变化。结论:给药后呼吸功能无明显变化。对DNase实施限制并未影响重症监护室或医院的LOS。对DNase排序限制的依从性可以得到改善。
{"title":"Use of dornase alfa in pediatric patients without cystic fibrosis.","authors":"Krishna C Daiya,&nbsp;Caroline M Sierra","doi":"10.1080/21548331.2023.2176041","DOIUrl":"https://doi.org/10.1080/21548331.2023.2176041","url":null,"abstract":"<p><strong>Objectives: </strong>Literature regarding clinical benefits of dornase alfa (DNase) in pediatric patients without cystic fibrosis is lacking. In December 2020, the study institution implemented restrictions to limit DNase use in this patient population. The primary objective was adherence to DNase ordering restrictions. Secondary objectives included length of stay, respiratory function, and use of inhaled mucolytic agents.</p><p><strong>Methods: </strong>This single-center retrospective chart review included patients less than 18 years of age who received DNase one year prior to through one year after order restriction implementation. Data collected included patient demographics and respiratory clinical parameters. Dosing regimens for DNase, n-acetylcysteine, and hypertonic saline were collected, as well as changes in length of stay (LOS) and adherence to ordering restrictions.</p><p><strong>Results: </strong>Of 101 total DNase orders, 45 were placed after implementation of ordering restrictions and 16 (36%) met all ordering criteria. Hospital and intensive care unit (ICU) LOS after implementation of restrictions were not significantly different (p = 0.767 and p = 0.219, respectively). There was no significant change in patients' mean oxygenation index (p = 0.252) or FiO2% (p = 0.113) 24 hours after DA administration.</p><p><strong>Conclusion: </strong>Respiratory function did not significantly change after DNase administration. Implementing restrictions on DNase did not impact intensive care unit or hospital LOS. Adherence to DNase ordering restrictions could be improved.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9563132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of healthcare facilities and personnel distribution in Lagos State: implications on universal health coverage. 评价拉各斯州的卫生保健设施和人员分布:对全民健康覆盖的影响。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.1080/21548331.2023.2170651
Maxwell Obubu, Nkata Chuku, Alozie Ananaba, Firdausi Umar Sadiq, Emmanuel Sambo, Oluwatosin Kolade, Tolulope Oyekanmi, Kehinde Olaosebikan, Oluwafemi Serrano

Background: Nigeria is considering making Universal Health Coverage (UHC) a common policy goal to ensure that citizens have access to high-quality healthcare services without crippling debt. Globally, there is an acute shortage of human resources for Health (HRH), and the most significant burden is borne by low-income countries, especially in sub-Saharan Africa. This shortage has considerably constrained the achievement of health-related development goals and impeded accelerated progress toward universal health coverage. We examine the existing human resource capacity and the distribution of health facilities in Lagos state in this study, discussing the implications of our findings.

Methods: The study is descriptive using secondary data analysis. We leverage census-based primary data collected by NOIPoll on health facility assessments in Lagos state. The collected data was analyzed using counts, ratios, rates, and percentages.

Results: We observe a ratio of 5,014 people to 1 general medical doctor, 2,942 people to 1 specialist, 2,165 people to 1 nurse, and 5,117 people to 1 midwife, which are far higher than the WHO recommendation. We also observe that the ratio of nurses to general medical practitioners is 2.2:1 in urban areas and 2.7:1 in rural. In contrast, the ratio of nurses to specialist medical doctors is 1.3:1 in the urban area and 1.5:1 in the rural areas of Lagos state. The overall nurse per general medical practitioner ratio is 2.3:1 and 1.4:1 for specialist medical doctors. 77.2% of the health facilities surveyed were in the urban areas, with private-for-profit facilities accounting for 82.9%, government facilities accounting for 15.4%, and NGOs/faith clinics accounting for 1.7%. Primary healthcare facilities account for 75.3% of the facilities surveyed, secondary and tertiary facilities account for 24.6% and 0.08%, respectively. Alimosho LGA has the most health facilities (77.38% PHCs, and 22.62% SHCs) and staff strength specifically for general medical practitioners, specialists, nurses, and midwives (16.9%, 19.9%, 16.7%, 17.1%, respectively). Eti-Osa LGA has the best density ratio for generalist doctors, specialist doctors, and nurses per 10,000 (4.42, 12.96, and 11.34 respectively), while Ikeja has the best midwife population density ratio 5.46 per 10,000 population.

Conclusion: The distribution of health personnel and facilities in Lagos State is not equitable, with evident variation between rural and urban areas. This inequitable distribution could affect the physical distance of health facilities to residents, leading to decreased utilization, ultimately poor health outcomes, and impaired access. Much like child mortality, maternal mortality also exhibits a correlation with healthcare worker density. As the physician density increases linearly, the maternal mortality rate decreases exponentially. However, due to the low number of healthcare

背景:尼日利亚正在考虑将全民健康覆盖(UHC)作为一项共同政策目标,以确保公民能够获得高质量的医疗保健服务,而不会造成严重债务。在全球范围内,卫生人力资源严重短缺,最严重的负担由低收入国家承担,特别是在撒哈拉以南非洲。这种短缺在很大程度上限制了与卫生有关的发展目标的实现,阻碍了在实现全民健康覆盖方面的加速进展。在本研究中,我们考察了拉各斯州现有的人力资源能力和卫生设施的分布,讨论了我们研究结果的含义。方法:采用二次资料分析方法进行描述性研究。我们利用NOIPoll收集的关于拉各斯州卫生设施评估的基于人口普查的原始数据。收集的数据使用计数、比率、比率和百分比进行分析。结果:全科医生和专科医生的比例分别为5014比1,专科医生和专科医生的比例分别为2942比1,护士和助产士的比例分别为2165比1,助产士和助产士的比例分别为5117比1,远远高于世界卫生组织推荐的比例。我们还观察到,护士与全科医生的比例在城市地区为2.2:1,在农村地区为2.7:1。相比之下,拉各斯州城市地区护士与专科医生的比例为1.3:1,农村地区为1.5:1。护士与全科医生的比率为2.3:1,专科医生为1.4:1。77.2%的受访卫生机构位于城市地区,其中私营营利性机构占82.9%,政府机构占15.4%,非政府组织/信仰诊所占1.7%。初级卫生保健设施占调查设施的75.3%,二级和三级卫生保健设施分别占24.6%和0.08%。Alimosho地方政府拥有最多的卫生设施(77.38%的初级保健中心和22.62%的初级保健中心)和专门为全科医生、专家、护士和助产士服务的工作人员(分别为16.9%、19.9%、16.7%和17.1%)。etii - osa LGA的全科医生、专科医生和护士的人口密度比最佳(分别为每万人4.42、12.96和11.34),而Ikeja的助产士人口密度比最佳(每万人5.46)。结论:拉各斯州卫生人员和设施分布不公平,城乡差异明显。这种不公平的分配可能会影响卫生设施与居民之间的实际距离,导致利用率下降,最终导致健康结果不佳,并妨碍获得服务。与儿童死亡率非常相似,孕产妇死亡率也与卫生保健工作者密度相关。随着医生密度线性增加,产妇死亡率呈指数级下降。然而,由于拉各斯州的卫生保健工作者人数少,在分娩期间经常没有医生、护士和助产士,导致婴儿、新生儿和孕产妇死亡人数增加。因此,政府应在该州的设施和人员分布中采用全民健康覆盖战略,以充分覆盖和优化设施的性能。此外,该州一些地区需要增加投资,以改善获得三级保健设施的机会,并利用私营部门的能力。
{"title":"Evaluation of healthcare facilities and personnel distribution in Lagos State: implications on universal health coverage.","authors":"Maxwell Obubu,&nbsp;Nkata Chuku,&nbsp;Alozie Ananaba,&nbsp;Firdausi Umar Sadiq,&nbsp;Emmanuel Sambo,&nbsp;Oluwatosin Kolade,&nbsp;Tolulope Oyekanmi,&nbsp;Kehinde Olaosebikan,&nbsp;Oluwafemi Serrano","doi":"10.1080/21548331.2023.2170651","DOIUrl":"https://doi.org/10.1080/21548331.2023.2170651","url":null,"abstract":"<p><strong>Background: </strong>Nigeria is considering making Universal Health Coverage (UHC) a common policy goal to ensure that citizens have access to high-quality healthcare services without crippling debt. Globally, there is an acute shortage of human resources for Health (HRH), and the most significant burden is borne by low-income countries, especially in sub-Saharan Africa. This shortage has considerably constrained the achievement of health-related development goals and impeded accelerated progress toward universal health coverage. We examine the existing human resource capacity and the distribution of health facilities in Lagos state in this study, discussing the implications of our findings.</p><p><strong>Methods: </strong>The study is descriptive using secondary data analysis. We leverage census-based primary data collected by NOIPoll on health facility assessments in Lagos state. The collected data was analyzed using counts, ratios, rates, and percentages.</p><p><strong>Results: </strong>We observe a ratio of 5,014 people to 1 general medical doctor, 2,942 people to 1 specialist, 2,165 people to 1 nurse, and 5,117 people to 1 midwife, which are far higher than the WHO recommendation. We also observe that the ratio of nurses to general medical practitioners is 2.2:1 in urban areas and 2.7:1 in rural. In contrast, the ratio of nurses to specialist medical doctors is 1.3:1 in the urban area and 1.5:1 in the rural areas of Lagos state. The overall nurse per general medical practitioner ratio is 2.3:1 and 1.4:1 for specialist medical doctors. 77.2% of the health facilities surveyed were in the urban areas, with private-for-profit facilities accounting for 82.9%, government facilities accounting for 15.4%, and NGOs/faith clinics accounting for 1.7%. Primary healthcare facilities account for 75.3% of the facilities surveyed, secondary and tertiary facilities account for 24.6% and 0.08%, respectively. Alimosho LGA has the most health facilities (77.38% PHCs, and 22.62% SHCs) and staff strength specifically for general medical practitioners, specialists, nurses, and midwives (16.9%, 19.9%, 16.7%, 17.1%, respectively). Eti-Osa LGA has the best density ratio for generalist doctors, specialist doctors, and nurses per 10,000 (4.42, 12.96, and 11.34 respectively), while Ikeja has the best midwife population density ratio 5.46 per 10,000 population.</p><p><strong>Conclusion: </strong>The distribution of health personnel and facilities in Lagos State is not equitable, with evident variation between rural and urban areas. This inequitable distribution could affect the physical distance of health facilities to residents, leading to decreased utilization, ultimately poor health outcomes, and impaired access. Much like child mortality, maternal mortality also exhibits a correlation with healthcare worker density. As the physician density increases linearly, the maternal mortality rate decreases exponentially. However, due to the low number of healthcare","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9216009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The role of carotid ultrasound in patients with non-lateralizing neurological complaints. 颈动脉超声在非侧化神经疾患患者中的作用。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.1080/21548331.2022.2144066
Shweta Varade, Abinayaa Ravichandran, Erafat Rehim, Hussam Yacoub, Rose Duncan, Hope Kincaid, Megan C Leary, John Castaldo

Objectives: In the United States, approximately 18-25% of carotid duplex ultrasound (CUS) studies are ordered to assess patients with non-lateralizing neurological complaints such as syncope, blurry vision, lightheadedness, headache, and altered mental status. The purpose of this study is to evaluate the benefit of CUS in the evaluation of patients presenting with non-lateralizing signs or symptoms.

Materials and methods: We conducted a retrospective analysis to assess the degree and laterality of carotid stenosis among patients with non-lateralizing neurological complaints who underwent CUS interpreted by certified vascular neurologists over a period of 3 years. The primary endpoint was to identify the prevalence of moderate-to-severe carotid artery stenosis among 280 patients who met inclusion criteria.

Results: A total of 17.7% of CUS studies were ordered for non-lateralizing symptoms. Two hundred and sixty-one patients (93.21%) had either normal imaging or mild carotid stenosis of <50%. Nineteen patients (6.79%) were found to have stenosis of ≥50%. In this subgroup, age and known preexisting carotid artery atherosclerotic disease were the only variables found to have a statistically significant association with the level of stenosis found on CUS. Two patients with asymptomatic stenosis of >70% underwent a revascularization procedure.

Conclusion: At least 17.7% of CUS studies were completed for non-lateralizing symptoms. The study is of low-yield with the prevalence of moderate-to-severe stenosis being comparable to that in the general asymptomatic population. We conclude that there is minimal clinical value in the use of CUS to investigate non-lateralizing neurological complaints, resulting in unnecessary healthcare costs.

目的:在美国,大约18-25%的颈动脉双相超声(CUS)研究被用于评估非侧化神经系统疾病,如晕厥、视力模糊、头晕、头痛和精神状态改变。本研究的目的是评估CUS在评估出现非侧化体征或症状的患者中的益处。材料和方法:我们进行了一项回顾性分析,以评估在3年的时间里由有资格的血管神经科医生进行CUS解释的非偏侧神经系统疾病患者的颈动脉狭窄程度和偏侧性。主要终点是确定280名符合纳入标准的患者中中度至重度颈动脉狭窄的患病率。结果:共有17.7%的CUS研究是针对非侧化症状。261例(93.21%)影像学正常或颈动脉轻度狭窄的患者(70%)接受了血管重建术。结论:至少17.7%的CUS研究是针对非侧化症状完成的。该研究是低收益的,中度至重度狭窄的患病率与一般无症状人群相当。我们的结论是,使用CUS来调查非侧化神经系统疾病的临床价值很小,导致不必要的医疗费用。
{"title":"The role of carotid ultrasound in patients with non-lateralizing neurological complaints.","authors":"Shweta Varade,&nbsp;Abinayaa Ravichandran,&nbsp;Erafat Rehim,&nbsp;Hussam Yacoub,&nbsp;Rose Duncan,&nbsp;Hope Kincaid,&nbsp;Megan C Leary,&nbsp;John Castaldo","doi":"10.1080/21548331.2022.2144066","DOIUrl":"https://doi.org/10.1080/21548331.2022.2144066","url":null,"abstract":"<p><strong>Objectives: </strong>In the United States, approximately 18-25% of carotid duplex ultrasound (CUS) studies are ordered to assess patients with non-lateralizing neurological complaints such as syncope, blurry vision, lightheadedness, headache, and altered mental status. The purpose of this study is to evaluate the benefit of CUS in the evaluation of patients presenting with non-lateralizing signs or symptoms.</p><p><strong>Materials and methods: </strong>We conducted a retrospective analysis to assess the degree and laterality of carotid stenosis among patients with non-lateralizing neurological complaints who underwent CUS interpreted by certified vascular neurologists over a period of 3 years. The primary endpoint was to identify the prevalence of moderate-to-severe carotid artery stenosis among 280 patients who met inclusion criteria.</p><p><strong>Results: </strong>A total of 17.7% of CUS studies were ordered for non-lateralizing symptoms. Two hundred and sixty-one patients (93.21%) had either normal imaging or mild carotid stenosis of <50%. Nineteen patients (6.79%) were found to have stenosis of ≥50%. In this subgroup, age and known preexisting carotid artery atherosclerotic disease were the only variables found to have a statistically significant association with the level of stenosis found on CUS. Two patients with asymptomatic stenosis of >70% underwent a revascularization procedure.</p><p><strong>Conclusion: </strong>At least 17.7% of CUS studies were completed for non-lateralizing symptoms. The study is of low-yield with the prevalence of moderate-to-severe stenosis being comparable to that in the general asymptomatic population. We conclude that there is minimal clinical value in the use of CUS to investigate non-lateralizing neurological complaints, resulting in unnecessary healthcare costs.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10701973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multisite analysis of patient experience scores and risk of hospital admission: a retrospective cohort study. 患者体验评分与入院风险的多站点分析:一项回顾性队列研究。
Q2 Medicine Pub Date : 2023-02-01 Epub Date: 2022-11-24 DOI: 10.1080/21548331.2022.2144055
Yousif M Hydoub, Karen M Fischer, Kristine T Hanson, Trevor J Coons, Laurie L Wilshusen, Tafi L Vista, Gretchen A Colbenson, M Caroline Burton, Elizabeth B Habermann, Sagar B Dugani

Background: Routinely collected patient experience scores may inform risk of patient outcomes. The objective of the study was to evaluate the risk of hospital admission within 30-days following third-party receipt of the patient experience survey and guide interventions.

Methods: In this retrospective cohort study, we analyzed Hospital Consumer Assessment of Healthcare Providers and Systems surveys, January 2016-July 2019, from an institution's 20 hospitals in four U.S. states. Surveys were routinely sent to patients using census sampling. We analyzed surveys received ≤60 days following discharge from patients living ≤60 miles of any of the institution's hospitals. The exposures were 19 survey items. The outcome was hospital admission within 30 days after third-party receipt of the survey. We evaluated the association of favorable (top-box) vs unfavorable (non-top-box) score for survey items with risk of 30-day hospital admission in models including patient and hospitalization characteristics and reported adjusted odds ratios (aOR [95% confidence interval]).

Results: Among 40,162 respondents (mean age ± standard deviation: 68.1 ± 14.0 years), 49.8% were women and 4.3% had 30-day hospital admission. Patients with 30-day hospital admission, compared to those not admitted, were more likely to be discharged from a medical service line (62.9% vs 42.3%; P < 0.001) and have a higher Elixhauser index. Favorable vs unfavorable score for hospital rating was associated with lower odds of 30-day hospital admission in the overall cohort (0.88 [0.77-0.99]; P = 0.04), medical service line (0.81 [0.70-0.94]; P = 0.007), and upper tertile of Elixhauser index (0.79 [0.67-0.92]; P = 0.003). Favorable score for recommend hospital was associated with lower odds of 30-day hospital admission in the medical service line (0.83 [0.71-0.97]; P = 0.02) but for others (e.g. cleanliness of hospital environment) showed no association.

Conclusion: In routinely collected patient experience scores, favorable hospital rating was associated with lower odds of 30-day hospital admission and may inform risk stratification and interventions. Evidence-based survey items linked to patient outcomes may also inform future surveys.

背景:常规收集的患者体验评分可为患者预后风险提供参考。本研究旨在评估第三方收到患者体验调查后 30 天内的入院风险,并为干预措施提供指导:在这项回顾性队列研究中,我们分析了 2016 年 1 月至 2019 年 7 月一家机构在美国四个州的 20 家医院进行的《医疗保健提供者和系统消费者评估》(Hospital Consumer Assessment of Healthcare Providers and Systems)调查。调查采用普查抽样的方式定期发送给患者。我们对出院后 60 天内收到的调查进行了分析,这些患者居住地距离该机构的任何一家医院均不超过 60 英里。调查对象包括 19 个调查项目。结果为第三方收到调查后 30 天内的入院情况。我们在包括患者和住院特征的模型中评估了调查项目的有利得分(顶格)与不利得分(非顶格)与 30 天入院风险的关系,并报告了调整后的几率比(aOR [95% 置信区间]):在 40,162 名受访者(平均年龄 ± 标准差:68.1 ± 14.0 岁)中,49.8% 为女性,4.3% 曾住院 30 天。与未入院患者相比,30 天入院患者更有可能从医疗服务线出院(62.9% vs 42.3%;P 医院评分与总体队列(0.88 [0.77-0.99];P = 0.04)、医疗服务线(0.81 [0.70-0.94];P = 0.007)和 Elixhauser 指数上四分位数(0.79 [0.67-0.92];P = 0.003)中 30 天入院几率较低有关。在医疗服务项目中,推荐医院的良好评分与较低的 30 天入院几率相关(0.83 [0.71-0.97];P = 0.02),但与其他项目(如医院环境清洁度)没有关联:结论:在常规收集的患者体验评分中,医院好评率与较低的 30 天入院几率相关,可为风险分层和干预措施提供参考。以证据为基础的调查项目与患者的治疗效果相关联,也可为今后的调查提供参考。
{"title":"Multisite analysis of patient experience scores and risk of hospital admission: a retrospective cohort study.","authors":"Yousif M Hydoub, Karen M Fischer, Kristine T Hanson, Trevor J Coons, Laurie L Wilshusen, Tafi L Vista, Gretchen A Colbenson, M Caroline Burton, Elizabeth B Habermann, Sagar B Dugani","doi":"10.1080/21548331.2022.2144055","DOIUrl":"10.1080/21548331.2022.2144055","url":null,"abstract":"<p><strong>Background: </strong>Routinely collected patient experience scores may inform risk of patient outcomes. The objective of the study was to evaluate the risk of hospital admission within 30-days following third-party receipt of the patient experience survey and guide interventions.</p><p><strong>Methods: </strong>In this retrospective cohort study, we analyzed Hospital Consumer Assessment of Healthcare Providers and Systems surveys, January 2016-July 2019, from an institution's 20 hospitals in four U.S. states. Surveys were routinely sent to patients using census sampling. We analyzed surveys received ≤60 days following discharge from patients living ≤60 miles of any of the institution's hospitals. The exposures were 19 survey items. The outcome was hospital admission within 30 days after third-party receipt of the survey. We evaluated the association of favorable (top-box) vs unfavorable (non-top-box) score for survey items with risk of 30-day hospital admission in models including patient and hospitalization characteristics and reported adjusted odds ratios (aOR [95% confidence interval]).</p><p><strong>Results: </strong>Among 40,162 respondents (mean age ± standard deviation: 68.1 ± 14.0 years), 49.8% were women and 4.3% had 30-day hospital admission. Patients with 30-day hospital admission, compared to those not admitted, were more likely to be discharged from a medical service line (62.9% vs 42.3%; <i>P</i> < 0.001) and have a higher Elixhauser index. Favorable vs unfavorable score for <i>hospital rating</i> was associated with lower odds of 30-day hospital admission in the overall cohort (0.88 [0.77-0.99]; <i>P</i> = 0.04), medical service line (0.81 [0.70-0.94]; <i>P</i> = 0.007), and upper tertile of Elixhauser index (0.79 [0.67-0.92]; <i>P</i> = 0.003). Favorable score for <i>recommend hospital</i> was associated with lower odds of 30-day hospital admission in the medical service line (0.83 [0.71-0.97]; <i>P</i> = 0.02) but for others (e.g. <i>cleanliness of hospital environment</i>) showed no association.</p><p><strong>Conclusion: </strong>In routinely collected patient experience scores, favorable <i>hospital rating</i> was associated with lower odds of 30-day hospital admission and may inform risk stratification and interventions. Evidence-based survey items linked to patient outcomes may also inform future surveys.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10735127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of language barriers on efficacy of rapid response teams. 语言障碍对快速反应小组效能的影响。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.1080/21548331.2022.2150416
Lauren Raff, Carlton Moore, Evan Raff

Objectives: Rapid response (RR) systems are associated with decreased hospital mortality. Systemic biases and inequities can negatively impact RR outcomes. Language barriers between patients and providers are associated with worse outcomes, but it is unknown if language barriers are associated with RR outcomes.

Methods: We analyzed all adult hospitalized patients who experienced a RR over one year (January 2020 to December 2020) at a tertiary care academic medical center. We used an objective scoring system to establish disease severity at the time of the event. We then compared disease severity and outcomes for patients who are primary language Spanish (PLS) and primary language English (PLE) using both univariable and multivariable analyses.

Results: Of 1133 patients, 42 identified as PLS and 1091 as PLE. In multivariable analyses, PLS patients had significantly higher disease severity scores, as measured by deterioration index score (8.2, p = 0.021) at the time of their rapid responses. PLS patients also had 18.5% increase in length of stay (LOS) after RRs and this disparity was not mitigated when controlling for disease severity at the time of RRs. PLS was not a significant predictor for hospital mortality after RRs.

Conclusions: Our study found that PLS patients had increased disease severity at the time of RRs and increased LOS after RRs. However, the disparity in LOS was not mitigated when controlling for disease severity at the time of RRs. These findings suggest that language barriers may cause both delays in activation of RR systems, as well as the care provided during and after RRs.

目的:快速反应(RR)系统与降低医院死亡率相关。系统性偏见和不公平会对RR结果产生负面影响。患者和医护人员之间的语言障碍与较差的结果相关,但语言障碍是否与RR结果相关尚不清楚。方法:我们分析了一年内(2020年1月至2020年12月)在三级医疗学术中心经历RR的所有成年住院患者。我们使用客观评分系统来确定事件发生时的疾病严重程度。然后,我们使用单变量和多变量分析比较了主要语言为西班牙语(PLS)和主要语言为英语(PLE)的患者的疾病严重程度和结局。结果:1133例患者中,42例为PLS, 1091例为PLE。在多变量分析中,PLS患者在快速反应时,通过恶化指数评分(8.2,p = 0.021)来衡量,疾病严重程度评分明显较高。PLS患者在rrrs后的住院时间(LOS)也增加了18.5%,在rrrs时控制疾病严重程度时,这一差异并未得到缓解。PLS不是rrrs后住院死亡率的显著预测因子。结论:我们的研究发现,PLS患者在rrrs时疾病严重程度增加,rrrs后LOS增加。然而,当控制rr发生时的疾病严重程度时,LOS的差异并没有得到缓解。这些发现表明,语言障碍可能会导致RR系统激活的延迟,以及RR期间和之后提供的护理。
{"title":"The role of language barriers on efficacy of rapid response teams.","authors":"Lauren Raff,&nbsp;Carlton Moore,&nbsp;Evan Raff","doi":"10.1080/21548331.2022.2150416","DOIUrl":"https://doi.org/10.1080/21548331.2022.2150416","url":null,"abstract":"<p><strong>Objectives: </strong>Rapid response (RR) systems are associated with decreased hospital mortality. Systemic biases and inequities can negatively impact RR outcomes. Language barriers between patients and providers are associated with worse outcomes, but it is unknown if language barriers are associated with RR outcomes.</p><p><strong>Methods: </strong>We analyzed all adult hospitalized patients who experienced a RR over one year (January 2020 to December 2020) at a tertiary care academic medical center. We used an objective scoring system to establish disease severity at the time of the event. We then compared disease severity and outcomes for patients who are primary language Spanish (PLS) and primary language English (PLE) using both univariable and multivariable analyses.</p><p><strong>Results: </strong>Of 1133 patients, 42 identified as PLS and 1091 as PLE. In multivariable analyses, PLS patients had significantly higher disease severity scores, as measured by deterioration index score (8.2, p = 0.021) at the time of their rapid responses. PLS patients also had 18.5% increase in length of stay (LOS) after RRs and this disparity was not mitigated when controlling for disease severity at the time of RRs. PLS was not a significant predictor for hospital mortality after RRs.</p><p><strong>Conclusions: </strong>Our study found that PLS patients had increased disease severity at the time of RRs and increased LOS after RRs. However, the disparity in LOS was not mitigated when controlling for disease severity at the time of RRs. These findings suggest that language barriers may cause both delays in activation of RR systems, as well as the care provided during and after RRs.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10806008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Perioperative management of emergency and elective surgeries during the pandemic. 大流行期间急诊和择期手术的围手术期管理。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.1080/21548331.2023.2166746
Sydney Boike, Mikael Mir, Holly Olson, Delaney Cole, Ibtisam Rauf, Salim Surani, Syed Anjum Khan

The effects of the 2019 novel coronavirus, SARS-CoV-2, and its associated pandemic are complex and widespread. It has permeated all aspects of daily life around the world. Unsurprisingly, it also had significant impacts on proceedings within hospitals around the world as well. Most notably, the multiple waves of the pandemic have each had untoward effects on surgical productivity within hospital systems. More specifically, the disruption of surgical procedures has impacted both emergent and elective cases. In the context of emergent procedures, hospital systems have had to reevaluate how they define 'emergent,' forcing them to determine which cases could not be rescheduled versus those that could. Elective procedures, on the other hand, were nearly halted altogether in the initial pandemic waves. If these were not completely stopped in some places, then they were greatly reduced. This paper will serve to describe the effect the pandemic has had on the proceedings of both elective and emergent surgeries. It will also describe how we have reevaluated and changed the way we define 'emergent' surgeries and describe the potential implications of this. We will also describe literature that speaks to the implications of the delay of elective procedures. Additionally, the cost implications of fewer surgical procedures performed will be discussed. Finally, we will describe literature that has established protocols for scheduling surgeries in waves of the pandemic, how these have evolved over time, and how they have created confusion for hospital systems navigating the pandemic.

2019年新型冠状病毒SARS-CoV-2及其相关大流行的影响是复杂和广泛的。它已经渗透到世界各地日常生活的方方面面。不出所料,它也对世界各地医院的程序产生了重大影响。最值得注意的是,多次流感大流行都对医院系统内的手术效率产生了不利影响。更具体地说,外科手术的中断影响了急诊和择期病例。在紧急程序的背景下,医院系统不得不重新评估他们如何定义“紧急”,迫使他们确定哪些病例不能重新安排,哪些可以重新安排。另一方面,在最初的大流行浪潮中,选择性程序几乎完全停止。如果这些在某些地方没有完全停止,那么它们就会大大减少。本文将描述大流行对选择性手术和紧急手术的影响。它还将描述我们如何重新评估和改变我们定义“紧急”手术的方式,并描述其潜在含义。我们还将描述文献,说到延迟选择性程序的含义。此外,减少外科手术的成本影响将被讨论。最后,我们将描述已经建立了在大流行期间安排手术的协议的文献,这些协议如何随着时间的推移而演变,以及它们如何给应对大流行的医院系统造成混乱。
{"title":"Perioperative management of emergency and elective surgeries during the pandemic.","authors":"Sydney Boike,&nbsp;Mikael Mir,&nbsp;Holly Olson,&nbsp;Delaney Cole,&nbsp;Ibtisam Rauf,&nbsp;Salim Surani,&nbsp;Syed Anjum Khan","doi":"10.1080/21548331.2023.2166746","DOIUrl":"https://doi.org/10.1080/21548331.2023.2166746","url":null,"abstract":"<p><p>The effects of the 2019 novel coronavirus, SARS-CoV-2, and its associated pandemic are complex and widespread. It has permeated all aspects of daily life around the world. Unsurprisingly, it also had significant impacts on proceedings within hospitals around the world as well. Most notably, the multiple waves of the pandemic have each had untoward effects on surgical productivity within hospital systems. More specifically, the disruption of surgical procedures has impacted both emergent and elective cases. In the context of emergent procedures, hospital systems have had to reevaluate how they define 'emergent,' forcing them to determine which cases could not be rescheduled versus those that could. Elective procedures, on the other hand, were nearly halted altogether in the initial pandemic waves. If these were not completely stopped in some places, then they were greatly reduced. This paper will serve to describe the effect the pandemic has had on the proceedings of both elective and emergent surgeries. It will also describe how we have reevaluated and changed the way we define 'emergent' surgeries and describe the potential implications of this. We will also describe literature that speaks to the implications of the delay of elective procedures. Additionally, the cost implications of fewer surgical procedures performed will be discussed. Finally, we will describe literature that has established protocols for scheduling surgeries in waves of the pandemic, how these have evolved over time, and how they have created confusion for hospital systems navigating the pandemic.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10711005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospitalization in maintenance peritoneal dialysis: a review. 维持性腹膜透析住院:综述。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.1080/21548331.2023.2170613
Braden Vogt, David F Painter, Rodrigo Saad Berreta, Anagha Lokhande, Ankur D Shah

Although hemodialysis continues to be the dominant form of dialysis in the United States, peritoneal dialysis rates continue to rise both nationally and worldwide. Peritoneal dialysis offers patients increased flexibility due to the ability to dialyze at home, leading to potential quality of life benefits for patients. However, questions exist regarding clinical outcomes in patients on peritoneal dialysis and the literature has not recently been reviewed. This review examines hospitalizations within patients utilizing peritoneal dialysis, including comparison to other dialysis modalities. Much heterogeneity exists within the literature, often explained by patient population. Recent data show all-cause, cardiovascular, and infection-related hospitalizations to be high in patients on peritoneal dialysis, although data variation limits conclusions in comparison to other modalities. This review found there is insufficient evidence to suggest admission rates are different in peritoneal dialysis than in-center hemodialysis. While the rate is similar to infectious causes, most studies report cardiovascular complications to be the leading cause of hospitalization. Some evidence suggests that cardiovascular hospitalizations occur at a higher rate in peritoneal dialysis, but further studies are required. The infection-related hospitalization rate appears to be higher in peritoneal dialysis due to rates of peritonitis, but rates of life-threatening bacteremia are lower. Differences in reporting of hospital days vs. length of stay challenge the interpretability of length of stay data between modalities, but patients on PD may spend more days per year in the hospital. In summary, hospitalization is highly prevalent in patients on peritoneal dialysis and few definitive conclusions can be drawn in comparison to other dialysis modalities. In eligible patient populations who desire increased flexibility, peritoneal dialysis is a reasonable modality choice.

尽管血液透析仍然是美国主要的透析形式,但腹膜透析率在全国和世界范围内都在继续上升。由于能够在家中进行透析,腹膜透析为患者提供了更大的灵活性,从而提高了患者的潜在生活质量。然而,关于腹膜透析患者的临床结果存在问题,并且最近没有文献回顾。本综述调查了腹膜透析患者的住院情况,包括与其他透析方式的比较。文献中存在许多异质性,通常由患者群体来解释。最近的数据显示,腹膜透析患者的全因、心血管和感染相关住院率很高,尽管数据差异限制了与其他方式相比的结论。本综述发现,没有足够的证据表明腹膜透析和中心血液透析的入院率不同。虽然这一比率与感染原因相似,但大多数研究报告心血管并发症是住院治疗的主要原因。一些证据表明,腹膜透析患者的心血管住院率更高,但需要进一步的研究。由于腹膜炎的发生率,腹膜透析中感染相关的住院率似乎较高,但危及生命的菌血症发生率较低。住院天数和住院时间报告的差异挑战了不同模式之间住院时间数据的可解释性,但PD患者每年在医院的时间可能更长。总之,腹膜透析患者的住院率很高,与其他透析方式相比,很少能得出明确的结论。在符合条件的患者群体谁希望增加灵活性,腹膜透析是一个合理的模式选择。
{"title":"Hospitalization in maintenance peritoneal dialysis: a review.","authors":"Braden Vogt,&nbsp;David F Painter,&nbsp;Rodrigo Saad Berreta,&nbsp;Anagha Lokhande,&nbsp;Ankur D Shah","doi":"10.1080/21548331.2023.2170613","DOIUrl":"https://doi.org/10.1080/21548331.2023.2170613","url":null,"abstract":"<p><p>Although hemodialysis continues to be the dominant form of dialysis in the United States, peritoneal dialysis rates continue to rise both nationally and worldwide. Peritoneal dialysis offers patients increased flexibility due to the ability to dialyze at home, leading to potential quality of life benefits for patients. However, questions exist regarding clinical outcomes in patients on peritoneal dialysis and the literature has not recently been reviewed. This review examines hospitalizations within patients utilizing peritoneal dialysis, including comparison to other dialysis modalities. Much heterogeneity exists within the literature, often explained by patient population. Recent data show all-cause, cardiovascular, and infection-related hospitalizations to be high in patients on peritoneal dialysis, although data variation limits conclusions in comparison to other modalities. This review found there is insufficient evidence to suggest admission rates are different in peritoneal dialysis than in-center hemodialysis. While the rate is similar to infectious causes, most studies report cardiovascular complications to be the leading cause of hospitalization. Some evidence suggests that cardiovascular hospitalizations occur at a higher rate in peritoneal dialysis, but further studies are required. The infection-related hospitalization rate appears to be higher in peritoneal dialysis due to rates of peritonitis, but rates of life-threatening bacteremia are lower. Differences in reporting of hospital days vs. length of stay challenge the interpretability of length of stay data between modalities, but patients on PD may spend more days per year in the hospital. In summary, hospitalization is highly prevalent in patients on peritoneal dialysis and few definitive conclusions can be drawn in comparison to other dialysis modalities. In eligible patient populations who desire increased flexibility, peritoneal dialysis is a reasonable modality choice.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9266037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-modality management of hypertrophic cardiomyopathy. 肥厚性心肌病的多模式治疗。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.1080/21548331.2022.2162297
Shiavax J Rao, Shaikh B Iqbal, Arjun S Kanwal, Wilbert S Aronow, Srihari S Naidu

Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited condition defined by left ventricular wall thickness greater than 15 mm in the absence of other conditions that could explain that degree of hypertrophy. Obstructive HCM associated with left ventricular outflow tract obstruction is defined by an intraventricular systolic pressure gradient greater than or equal to 30 mm Hg. Over the past couple of decades, there has been an expansion of both invasive and pharmacotherapeutic options for patients with HCM, with recent guidelines calling for a melody of invasive and non-invasive treatment strategies. There are several invasive therapies including proven therapies such as alcohol septal ablation and septal myectomy. Novel invasive therapies such as MitraClip, radiofrequency septal ablation and SESAME procedure have more recently been promoted. Pharmacological therapy has also dramatically evolved and includes conventional medications such as beta-blockers, calcium channel blockers, and disopyramide. Mavacamten, a novel cardiac myosin inhibitor, may significantly change management. Other myosin inhibitors and modulators are also being developed and tested in large clinical trials. Given significant phenotypical variability in patients with HCM, clinical management can be challenging, and often requires an individualized approach with a combination of invasive and non-invasive options.

肥厚性心肌病(HCM)是一种常染色体显性遗传病,定义为左心室壁厚度大于15mm,没有其他条件可以解释肥厚程度。伴有左心室流出道梗阻的梗阻性HCM由心室内收缩压梯度大于或等于30mmhg来定义。在过去的几十年里,HCM患者的侵入性和药物治疗选择不断扩大,最近的指南呼吁采用侵入性和非侵入性治疗策略。有几种侵入性治疗方法,包括已证实的治疗方法,如酒精室间隔消融和室间隔肌切除术。新的侵入性治疗,如MitraClip,射频间隔消融和SESAME手术最近得到了推广。药理学治疗也发生了巨大的变化,包括传统的药物治疗,如-受体阻滞剂、钙通道阻滞剂和双酰胺。Mavacamten,一种新型心肌肌球蛋白抑制剂,可能会显著改变治疗方法。其他肌球蛋白抑制剂和调节剂也正在开发中,并在大型临床试验中进行测试。考虑到HCM患者显著的表型变异性,临床管理可能具有挑战性,通常需要结合侵入性和非侵入性选择的个性化方法。
{"title":"Multi-modality management of hypertrophic cardiomyopathy.","authors":"Shiavax J Rao,&nbsp;Shaikh B Iqbal,&nbsp;Arjun S Kanwal,&nbsp;Wilbert S Aronow,&nbsp;Srihari S Naidu","doi":"10.1080/21548331.2022.2162297","DOIUrl":"https://doi.org/10.1080/21548331.2022.2162297","url":null,"abstract":"<p><p>Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited condition defined by left ventricular wall thickness greater than 15 mm in the absence of other conditions that could explain that degree of hypertrophy. Obstructive HCM associated with left ventricular outflow tract obstruction is defined by an intraventricular systolic pressure gradient greater than or equal to 30 mm Hg. Over the past couple of decades, there has been an expansion of both invasive and pharmacotherapeutic options for patients with HCM, with recent guidelines calling for a melody of invasive and non-invasive treatment strategies. There are several invasive therapies including proven therapies such as alcohol septal ablation and septal myectomy. Novel invasive therapies such as MitraClip, radiofrequency septal ablation and SESAME procedure have more recently been promoted. Pharmacological therapy has also dramatically evolved and includes conventional medications such as beta-blockers, calcium channel blockers, and disopyramide. Mavacamten, a novel cardiac myosin inhibitor, may significantly change management. Other myosin inhibitors and modulators are also being developed and tested in large clinical trials. Given significant phenotypical variability in patients with HCM, clinical management can be challenging, and often requires an individualized approach with a combination of invasive and non-invasive options.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9281235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Authors' reply, re: A response to Zhou et al. regarding thiamine supplementation in altered mental status. 作者回复:对Zhou等人关于补充硫胺素对改变精神状态的影响的回应。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.1080/21548331.2023.2170154
Daniel J Zhou, Sachin Kedar
We thank Drs. Trebach and Hoffman for their thoughtful remarks and use this opportunity to discuss their concerns. We acknowledge the limitations of a single institution-based, retrospective, cohort study and have addressed these in our manuscript extensively [1]. In this practice-based, real-world study, we examined hospital outcomes and thiamine prescription patterns among a diverse group of hospital-based providers who were licensed and credentialed to manage patients with altered mental status from all-causes, including those with hypoglycemia. While we found wide variations in the thiamine prescription patterns (timing, dosage, and route of administration), we are not unique in reporting such variations in clinical practice [2– 6]. It is possible that differences in prescription patterns such as glucose-first vs. thiamine-first or parenteral vs. enteral vs. no thiamine could be the result of disease severity. While we controlled for disease severity using Medicare Severity Diagnosis-Related Group (MS-DRG) weight in our models, it is possible that this measure may not have captured the breadth of clinical severity. Additional analyses of the effects of different dosages on outcomes were not feasible due to wide variations in clinical practice resulting in small patient numbers in groups. We acknowledge the growing evidence for the lack of benefit of supplemental thiamine in critically ill patients [7,8]. It has also been reported that glucose administration before or without thiamine would not acutely worsen the effects of thiamine deficiency unless the glucose administration is prolonged [9]. However, in our study, we found that patients who received glucose before or without thiamine had increased inhospital mortality rate after controlling for disease severity. Based on the results of our study, we cannot in good conscience, argue against the current medical practice (dogma) of administering parenteral thiamine before glucose for critically ill patients with altered mental status from all causes.
{"title":"Authors' reply, re: A response to Zhou et al. regarding thiamine supplementation in altered mental status.","authors":"Daniel J Zhou,&nbsp;Sachin Kedar","doi":"10.1080/21548331.2023.2170154","DOIUrl":"https://doi.org/10.1080/21548331.2023.2170154","url":null,"abstract":"We thank Drs. Trebach and Hoffman for their thoughtful remarks and use this opportunity to discuss their concerns. We acknowledge the limitations of a single institution-based, retrospective, cohort study and have addressed these in our manuscript extensively [1]. In this practice-based, real-world study, we examined hospital outcomes and thiamine prescription patterns among a diverse group of hospital-based providers who were licensed and credentialed to manage patients with altered mental status from all-causes, including those with hypoglycemia. While we found wide variations in the thiamine prescription patterns (timing, dosage, and route of administration), we are not unique in reporting such variations in clinical practice [2– 6]. It is possible that differences in prescription patterns such as glucose-first vs. thiamine-first or parenteral vs. enteral vs. no thiamine could be the result of disease severity. While we controlled for disease severity using Medicare Severity Diagnosis-Related Group (MS-DRG) weight in our models, it is possible that this measure may not have captured the breadth of clinical severity. Additional analyses of the effects of different dosages on outcomes were not feasible due to wide variations in clinical practice resulting in small patient numbers in groups. We acknowledge the growing evidence for the lack of benefit of supplemental thiamine in critically ill patients [7,8]. It has also been reported that glucose administration before or without thiamine would not acutely worsen the effects of thiamine deficiency unless the glucose administration is prolonged [9]. However, in our study, we found that patients who received glucose before or without thiamine had increased inhospital mortality rate after controlling for disease severity. Based on the results of our study, we cannot in good conscience, argue against the current medical practice (dogma) of administering parenteral thiamine before glucose for critically ill patients with altered mental status from all causes.","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9931179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hospital practice (1995)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1